https://news.medxy.ai/zh/12-13-dihome-prognostic-biomarker/Medxy AIzh2026-10-21T07:28:57-07:0012,13-diHOME：心搏骤停后靶向体温管理中棕色脂肪激活与预后的潜在标志物 https://news.medxy.ai/ja/dihome-biomarker-outcomes/Medxy AIja2026-10-21T07:28:35-07:0012,13-diHOME高値は心停止後TTMにおける褐色脂肪組織活性化と良好転帰の指標となりうる https://news.medxy.ai/vi/dihome-cardiac-arrest-temperature-control/Medxy AIvi2026-10-21T07:28:11-07:0012,13-diHOME: Dấu ấn tiềm năng của hoạt hóa mô mỡ nâu và tiên lượng trong kiểm soát thân nhiệt sau ngừng tim https://news.medxy.ai/1213-dihome-levels-as-a-marker-of-brown-adipose-tissue-activation-and-outcome-in-targeted-temperature-management-post-cardiac-arrest/Medxy AIen2026-10-21T07:27:47-07:0012,13-diHOME Levels as a Marker of Brown Adipose Tissue Activation and Outcome in Targeted Temperature Management Post-Cardiac Arrest https://news.medxy.ai/zh/encircle-tmvr-outcomes/Medxy AIzh2026-10-21T07:27:10-07:00SAPIEN M3 经房间隔 TMVR：ENCIRCLE MAC 注册研究二尖瓣瓣环钙化患者 1 年结局 https://news.medxy.ai/ja/transseptal-tmvr-mac-registry/Medxy AIja2026-10-21T07:26:48-07:00SAPIEN M3システムによる経中隔TMVR：ENCIRCLE MAC Registryが示した僧帽弁輪石灰化患者の1年成績 https://news.medxy.ai/vi/one-year-outcomes-sapien-m3-transseptal-mitral-valve-replacement/Medxy AIvi2026-10-21T07:26:25-07:00Kết quả 1 năm của thay van hai lá qua vách liên nhĩ bằng hệ thống SAPIEN M3 ở bệnh nhân vôi hóa vòng van hai lá từ sổ đăng ký ENCIRCLE MAC https://news.medxy.ai/transseptal-tmvr-using-the-sapien-m3-system-1-year-outcomes-in-patients-with-mitral-annular-calcification-from-the-encircle-mac-registry/Medxy AIen2026-10-21T07:26:05-07:00Transseptal TMVR Using the SAPIEN M3 System: 1-Year Outcomes in Patients with Mitral Annular Calcification from the ENCIRCLE MAC Registry https://news.medxy.ai/zh/high-impact-activity-arthritis-risk/Medxy AIzh2026-10-21T07:25:30-07:00高冲击体力活动会影响髋、膝骨关节炎的关节置换风险吗？一项大规模纵向中介研究 https://news.medxy.ai/ja/high-impact-exercise-joint-replacement-risk/Medxy AIja2026-10-21T07:25:07-07:00股関節・膝OAにおける高衝撃運動と関節置換リスク：大規模縦断媒介分析 https://news.medxy.ai/vi/high-impact-activity-joint-replacement/Medxy AIvi2026-10-21T07:24:42-07:00Hoạt động thể chất cường độ tác động mạnh và nguy cơ thay khớp ở thoái hóa khớp háng, gối: một nghiên cứu dọc quy mô lớn về vai trò trung gian https://news.medxy.ai/high-impact-physical-activity-and-joint-replacement-risk-in-hip-and-knee-osteoarthritis-a-large-scale-longitudinal-mediation-study/Medxy AIen2026-10-21T07:24:21-07:00High-Impact Physical Activity and Joint Replacement Risk in Hip and Knee Osteoarthritis: A Large-Scale Longitudinal Mediation Study https://news.medxy.ai/zh/emergency-surgery-recovery/Medxy AIzh2026-10-21T07:23:44-07:00急诊腹部手术后，综合呼吸与功能训练可促进撤机并加速恢复：来自随机对照试验的启示 https://news.medxy.ai/ja/accelerated-recovery-training/Medxy AIja2026-10-21T07:23:25-07:00呼吸・機能訓練の統合で離脱と回復を加速：緊急開腹手術RCTからの示唆 https://news.medxy.ai/vi/respiratory-training-ventilator-weaning/Medxy AIvi2026-10-21T07:23:02-07:00Kết hợp huấn luyện hô hấp và chức năng giúp tăng tỷ lệ cai máy thở và phục hồi sau phẫu thuật bụng cấp cứu: Góc nhìn từ một thử nghiệm đối chứng ngẫu nhiên https://news.medxy.ai/integrated-respiratory-and-functional-training-enhances-weaning-and-recovery-after-emergency-abdominal-surgery-insights-from-a-randomized-controlled-trial/Medxy AIen2026-10-21T07:22:43-07:00Integrated Respiratory and Functional Training Enhances Weaning and Recovery After Emergency Abdominal Surgery: Insights from a Randomized Controlled Trial https://news.medxy.ai/zh/peri-implant-soft-tissue-enhancement/Medxy AIzh2026-10-21T07:22:05-07:00优化种植体周围软组织维度：骨嵴软组织增量的时机与材料选择 https://news.medxy.ai/ja/optimizing-implant-tissue-enhancement/Medxy AIja2026-10-21T07:21:41-07:00歯槽頂部軟組織増大の最適化：インプラント周囲組織を高める時期と材料 https://news.medxy.ai/vi/implant-soft-tissue-augmentation/Medxy AIvi2026-10-21T07:21:14-07:00Tối ưu hóa kích thước mô quanh implant: Thời điểm và vật liệu trong tăng cường mô mềm vùng mào https://news.medxy.ai/optimizing-peri-implant-tissue-dimensions-timing-and-materials-in-crestal-soft-tissue-augmentation/Medxy AIen2026-10-21T07:20:54-07:00Optimizing Peri-Implant Tissue Dimensions: Timing and Materials in Crestal Soft-Tissue Augmentation https://news.medxy.ai/zh/ponatinib-blinatumomab-vs-imatinib-chemo/Medxy AIzh2026-10-21T07:20:17-07:00Ponatinib 联合 Blinatumomab 对比 Imatinib 联合化疗：推进成人 Philadelphia 染色体阳性 ALL 的一线治疗 https://news.medxy.ai/ja/ponatinib-blinatumomab-vs-imatinib-chemotherapy/Medxy AIja2026-10-21T07:19:56-07:00ponatinib＋blinatumomabはimatinib＋化学療法を上回るのか――成人Ph陽性ALLの一次治療を変える第3相試験 https://news.medxy.ai/vi/ponatinib-blinatumomab-all-treatment/Medxy AIvi2026-10-21T07:19:33-07:00Ponatinib phối hợp Blinatumomab so với Imatinib và Hóa trị: Bước tiến trong điều trị tuyến đầu ALL dương tính với Philadelphia ở người lớn https://news.medxy.ai/ponatinib-plus-blinatumomab-vs-imatinib-and-chemotherapy-advancing-frontline-therapy-in-adult-philadelphia-positive-all/Medxy AIen2026-10-21T07:19:13-07:00Ponatinib Plus Blinatumomab vs. Imatinib And Chemotherapy: Advancing Frontline Therapy in Adult Philadelphia-Positive ALL https://news.medxy.ai/zh/explainable-ai-oct-outcome-prediction/Medxy AIzh2026-10-21T07:15:41-07:00用可解释AI驱动的OCT生物标志物预测中心性浆液性脉络膜视网膜病变结局：来自多中心队列研究的启示 https://news.medxy.ai/ja/interpretable-ai-retinopathy-prognosis/Medxy AIja2026-10-21T07:15:24-07:00解釈可能AIで読み解く中心性漿液性脈絡網膜症の予後予測：多施設コホート研究からの知見 https://news.medxy.ai/vi/central-serous-retinopathy-prediction/Medxy AIvi2026-10-21T07:15:01-07:00Dự đoán diễn tiến bệnh lý hắc võng mạc trung tâm thanh dịch bằng AI có khả năng diễn giải từ biomarker OCT: Kết quả từ một nghiên cứu đoàn hệ đa trung tâm https://news.medxy.ai/predicting-central-serous-chorioretinopathy-outcomes-using-interpretable-ai-driven-oct-biomarkers-insights-from-a-multicenter-cohort-study/Medxy AIen2026-10-21T07:14:43-07:00Predicting Central Serous Chorioretinopathy Outcomes Using Interpretable AI-Driven OCT Biomarkers: Insights from a Multicenter Cohort Study https://news.medxy.ai/zh/facial-synkinesis-phenotypes/Medxy AIzh2026-10-21T07:14:03-07:00面部联动异常静息期表型分层：对手术规划的启示 https://news.medxy.ai/ja/facial-synkinesis-phenotype/Medxy AIja2026-10-21T07:13:44-07:00顔面連合運動の静止時表現型を読み解く：外科計画への示唆 https://news.medxy.ai/vi/resting-facial-synergies/Medxy AIvi2026-10-21T07:13:15-07:00Ba kiểu hình đồng vận mặt lúc nghỉ: Gợi ý quan trọng cho lập kế hoạch phẫu thuật https://news.medxy.ai/phenotypic-stratification-of-facial-synkinesis-resting-states-implications-for-surgical-planning/Medxy AIen2026-10-21T07:13:00-07:00Phenotypic Stratification of Facial Synkinesis Resting States: Implications for Surgical Planning https://news.medxy.ai/zh/acute-normovolemic-hemodilution-safety/Medxy AIzh2026-10-21T07:12:20-07:00女性心脏手术中急性等容性稀释的效果与安全性：血液保护策略是否仍需调整？ https://news.medxy.ai/ja/reassessing-acute-normovolemic-hemodilution/Medxy AIja2026-10-21T07:12:03-07:00女性の心臓手術における急性等容量血液希釈を再検証：有効性・安全性・臨床的意義 https://news.medxy.ai/vi/acute-isovolemic-hemodilution-heart-surgery/Medxy AIvi2026-10-21T07:11:40-07:00Trích máu pha loãng đẳng tích cấp tính ở phụ nữ phẫu thuật tim: Hiệu quả, độ an toàn và ý nghĩa lâm sàng https://news.medxy.ai/evaluating-acute-normovolemic-hemodilution-in-women-undergoing-cardiac-surgery-efficacy-safety-and-clinical-implications/Medxy AIen2026-10-21T07:11:23-07:00Evaluating Acute Normovolemic Hemodilution in Women Undergoing Cardiac Surgery: Efficacy, Safety, and Clinical Implications https://news.medxy.ai/zh/postpartum-blood-pressure-monitoring/Medxy AIzh2026-10-21T07:10:46-07:00产后 6 周血压监测：可预测妊娠期高血压女性的长期心血管风险 https://news.medxy.ai/ja/postpartum-blood-pressure-monitoring-3/Medxy AIja2026-10-21T07:10:26-07:00妊娠高血圧性疾患後の産後血圧モニタリングが将来の心血管リスクを予測する https://news.medxy.ai/vi/postpartum-blood-pressure-monitoring-2/Medxy AIvi2026-10-21T07:10:06-07:00Theo dõi huyết áp sau sinh ở phụ nữ có rối loạn tăng huyết áp thai kỳ dự báo nguy cơ tim mạch lâu dài https://news.medxy.ai/postpartum-blood-pressure-monitoring-after-hypertensive-disorders-of-pregnancy-predicts-long-term-cardiovascular-risk/Medxy AIen2026-10-21T07:09:47-07:00Postpartum Blood Pressure Monitoring After Hypertensive Disorders of Pregnancy Predicts Long-Term Cardiovascular Risk https://news.medxy.ai/zh/saroglitazar-pcos-masld-hope/Medxy AIzh2026-10-21T07:09:09-07:00Saroglitazar为PCOS合并MASLD女性的肝脂肪变性治疗带来新希望：一项多中心试验的启示 https://news.medxy.ai/ja/saroglitazar-pcos-liver-fat/Medxy AIja2026-10-21T07:08:46-07:00PCOS合併MASLD女性の肝脂肪化にSaroglitazarが有望：多施設共同試験からの知見 https://news.medxy.ai/vi/saroglitazar-pcos-masld-trial/Medxy AIvi2026-10-21T07:08:26-07:00Saroglitazar cho thấy triển vọng trong điều trị gan nhiễm mỡ ở phụ nữ mắc PCOS và MASLD: Góc nhìn từ một thử nghiệm đa trung tâm https://news.medxy.ai/saroglitazar-shows-promise-in-treating-hepatic-steatosis-in-women-with-pcos-and-masld-insights-from-a-multicenter-trial/Medxy AIen2026-10-21T07:08:10-07:00Saroglitazar Shows Promise in Treating Hepatic Steatosis in Women with PCOS and MASLD: Insights from a Multicenter Trial https://news.medxy.ai/zh/infections-alzheimers-neuropathologyorrelation/Medxy AIzh2026-10-21T07:07:33-07:00常见感染与阿尔茨海默病神经病理之间有何关联？——来自英国前瞻性队列研究的启示 https://news.medxy.ai/ja/common-infections-alzheimers-link/Medxy AIja2026-10-21T07:07:14-07:00一般的感染症とアルツハイマー病神経病理の関連を探る：英国前向きコホート研究からの知見 https://news.medxy.ai/vi/common-infections-alzheimers-link-2/Medxy AIvi2026-10-21T07:06:51-07:00Khám phá mối liên hệ giữa các nhiễm trùng thường gặp và bệnh lý thần kinh Alzheimer: Góc nhìn từ một nghiên cứu đoàn hệ tiến cứu tại Vương quốc Anh https://news.medxy.ai/infections-alzheimers-link/Medxy AIen2026-10-21T07:05:28-07:00Exploring the Link Between Common Infections and Alzheimer’s Disease Neuropathology: Insights From a UK Prospective Cohort Study https://news.medxy.ai/ja/heart-failure-definition-2026-3/Medxy AIja2026-10-21T07:04:45-07:00心不全の「第2版国際定義」2026年版：AHA/ACC/ESC/WHFコンセンサスの主要変更点と臨床への示唆 https://news.medxy.ai/vi/aha-heart-failure-definition/Medxy AIvi2026-10-21T07:04:15-07:00“Định nghĩa quốc tế về suy tim – Phiên bản thứ 2” (năm 2026): Những thay đổi chính trong sự đồng thuận của AHA/ACC/ESC/WHF và ý nghĩa đối với thực hành lâm sàng https://news.medxy.ai/zh/heart-failure-definition-2026-2/Medxy AIzh2026-10-21T07:03:43-07:002026版心力衰竭第二次统一定义：AHA/ACC/ESC/WHF专家共识的关键变化与临床要点 https://news.medxy.ai/second-universal-definition-of-heart-failure-2026-key-changes-and-clinical-guidance-from-the-aha-acc-esc-whf-expert-consensus/Medxy AIen2026-10-21T07:03:08-07:00Second Universal Definition of Heart Failure (2026): Key Changes and Clinical Guidance from the AHA/ACC/ESC/WHF Expert Consensus https://news.medxy.ai/zh/msi-high-gastric-cancer-immunotherapy/Medxy AIzh2026-10-21T07:02:10-07:00MSI-high 胃癌与胃食管结合部腺癌新辅助 nivolumab 联合 ipilimumab 的长期疗效：来自 NEONIPIGA 2 期试验的启示 https://news.medxy.ai/ja/neoadjuvant-immunotherapy-gastric-cancer/Medxy AIja2026-10-21T07:01:49-07:00MSI-high胃・胃食道接合部腺癌に対するニボルマブ／イピリムマブ術前療法の長期成績：第2相NEONIPIGA試験からの知見 https://news.medxy.ai/vi/long-term-outcomes-immunotherapy-gastric-cancer/Medxy AIvi2026-10-21T07:01:27-07:00Kết cục dài hạn của nivolumab và ipilimumab trước phẫu thuật trong ung thư biểu mô tuyến dạ dày và GEJ MSI-high: Góc nhìn từ thử nghiệm pha 2 NEONIPIGA https://news.medxy.ai/long-term-outcomes-of-neoadjuvant-nivolumab-and-ipilimumab-in-msi-high-gastric-and-gej-adenocarcinoma-insights-from-the-phase-2-neonipiga-trial/Medxy AIen2026-10-21T07:01:10-07:00Long-term Outcomes of Neoadjuvant Nivolumab and Ipilimumab in MSI-High Gastric and GEJ Adenocarcinoma: Insights from the Phase 2 NEONIPIGA Trial https://news.medxy.ai/zh/alignment-changes-after-acl-reconstruction/Medxy AIzh2026-10-21T07:00:27-07:00接近骨骼成熟期经骨骺前交叉韧带重建后的力线变化：PLUTO研究组的观察 https://news.medxy.ai/ja/alignment-changes-after-acl-reconstruction-3/Medxy AIja2026-10-21T07:00:06-07:00骨成熟直前の経骨端線ACL再建術後に生じるアライメント変化をどう捉えるか——PLUTO Study Groupの知見 https://news.medxy.ai/vi/alignment-changes-after-acl-reconstruction-2/Medxy AIvi2026-10-21T06:59:43-07:00Thay đổi thẳng trục sau tái tạo dây chằng chéo trước xuyên sụn tăng trưởng gần trưởng thành xương: Kinh nghiệm từ nhóm nghiên cứu PLUTO https://news.medxy.ai/navigating-alignment-changes-after-transphyseal-acl-reconstruction-near-skeletal-maturity-insights-from-the-pluto-study-group/Medxy AIen2026-10-21T06:59:25-07:00Navigating Alignment Changes After Transphyseal ACL Reconstruction Near Skeletal Maturity: Insights from the PLUTO Study Group https://news.medxy.ai/zh/pilates-fibromyalgia-rehabilitation/Medxy AIzh2026-10-21T06:58:49-07:00普拉提联合自我筋膜放松：6个月远程监督康复为纤维肌痛管理带来新思路 https://news.medxy.ai/ja/fibromyalgia-management/Medxy AIja2026-10-21T06:58:28-07:00ピラティスと自己筋膜リリースを組み合わせた6か月監督下テレリハビリテーションによる線維筋痛症管理の改善 https://news.medxy.ai/enhanced-fibromyalgia-management-through-six-month-supervised-telerehabilitation-integrating-pilates-and-self-myofascial-release/Medxy AIen2026-10-21T06:57:50-07:00Enhanced Fibromyalgia Management Through Six-Month Supervised Telerehabilitation: Integrating Pilates and Self-Myofascial Release https://news.medxy.ai/digitally-guided-root-membrane-preparation-using-a-dedicated-apex-guide-for-immediate-implant-placement-a-retrospective-case-series/Medxy AIen2026-10-21T06:57:17-07:00Digitally Guided Root Membrane Preparation Using a Dedicated Apex Guide for Immediate Implant Placement: A Retrospective Case Series https://news.medxy.ai/zh/shortened-hepatitis-c-treatment/Medxy AIzh2026-10-21T06:56:39-07:00慢性丙型肝炎无肝硬化患者的索磷布韦/维帕他韦疗程缩短：来自印度 RESOLVE 试验的证据 https://news.medxy.ai/ja/short-course-hepatitis-c-treatment/Medxy AIja2026-10-21T06:56:20-07:00非肝硬変慢性C型肝炎におけるソホスブビル・ベルパタスビル短期治療：インドRESOLVE試験のエビデンス https://news.medxy.ai/vi/shortened-sofosbuvir-velpatasvir-treatment/Medxy AIvi2026-10-21T06:56:01-07:00Rút ngắn điều trị Sofosbuvir-Velpatasvir cho viêm gan C mạn tính không xơ gan: Bằng chứng từ thử nghiệm RESOLVE tại Ấn Độ https://news.medxy.ai/shortening-sofosbuvir-velpatasvir-therapy-for-non-cirrhotic-chronic-hepatitis-c-evidence-from-the-resolve-trial-in-india/Medxy AIen2026-10-21T06:55:44-07:00Shortening Sofosbuvir-Velpatasvir Therapy for Non-Cirrhotic Chronic Hepatitis C: Evidence from the RESOLVE Trial in India https://news.medxy.ai/zh/pediatric-social-risk-screening/Medxy AIzh2026-10-21T06:55:06-07:00儿科住院社会风险筛查与转介实践现状：一项全国调查 https://news.medxy.ai/ja/social-risk-screening-referrals/Medxy AIja2026-10-21T06:54:52-07:00小児入院医療における社会的リスク・スクリーニングと紹介の実態：全国調査 https://news.medxy.ai/vi/social-risk-screening-referrals-2/Medxy AIvi2026-10-21T06:54:27-07:00Sàng lọc nguy cơ xã hội và thực hành chuyển tuyến trong nhi khoa nội trú: Kết quả từ một khảo sát quốc gia https://news.medxy.ai/assessing-social-risk-screening-and-referral-practices-in-pediatric-inpatient-care-a-national-survey/Medxy AIen2026-10-21T06:54:09-07:00Assessing Social Risk Screening and Referral Practices in Pediatric Inpatient Care: A National Survey https://news.medxy.ai/zh/neutrophil-lymphocyte-ratio-skin-cancer/Medxy AIzh2026-10-21T06:43:15-07:00高风险皮肤鳞状细胞癌中中性粒细胞/淋巴细胞比值的预后价值 https://news.medxy.ai/ja/neutrophil-lymphocyte-ratio/Medxy AIja2026-10-21T06:42:55-07:00高リスク皮膚扁平上皮癌における予後バイオマーカーとしての好中球/リンパ球比 https://news.medxy.ai/vi/neutrophil-lymphocyte-ratio-2/Medxy AIvi2026-10-21T06:42:34-07:00Tỷ lệ bạch cầu trung tính/bạch cầu lympho: dấu ấn tiên lượng trong ung thư biểu mô tế bào vảy da nguy cơ cao https://news.medxy.ai/neutrophil-to-lymphocyte-ratio-as-a-prognostic-biomarker-in-high-risk-cutaneous-squamous-cell-carcinoma/Medxy AIen2026-10-21T06:42:14-07:00Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in High-Risk Cutaneous Squamous Cell Carcinoma https://news.medxy.ai/zh/long-term-breast-reduction-lift-results/Medxy AIzh2026-10-21T06:41:35-07:00改良 Liacyr-Ribeiro 技术在乳房缩小与上提中的长期稳定效果 https://news.medxy.ai/ja/breast-reduction-lift-long-term-results/Medxy AIja2026-10-21T06:41:14-07:00乳房縮小・挙上術における改良Liacyr-Ribeiro法の長期的な安定した効果 https://news.medxy.ai/vi/long-term-breast-reduction-lift-results-2/Medxy AIvi2026-10-21T06:40:45-07:00Kết quả lâu dài bền vững của kỹ thuật Modified Liacyr-Ribeiro trong thu nhỏ tuyến vú và nâng tuyến vú https://news.medxy.ai/durable-long-term-outcomes-of-the-modified-liacyr-ribeiro-technique-in-breast-reduction-and-mastopexy/Medxy AIen2026-10-21T06:40:23-07:00Durable Long-Term Outcomes of the Modified Liacyr-Ribeiro Technique in Breast Reduction and Mastopexy